April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Sutureless Cryopreserved Amniotic Membrane Graft (ProKeraTM) and Wound Healing After Photorefractive Keratectomy (PRK)
K. S. Bower; C. D. Coe; D. S. Ryan; L. Peppers; R. K. Sia; R. S. Howard; S. Tauber; S. C. G. Tseng
Author Affiliations & Notes
  • K. S. Bower
    Center for Refractive Surgery,
    Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • C. D. Coe
    Center for Refractive Surgery,
    Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • D. S. Ryan
    Center for Refractive Surgery,
    Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • L. Peppers
    Center for Refractive Surgery,
    Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • R. K. Sia
    Center for Refractive Surgery,
    Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • R. S. Howard
    Department of Clinical Investigation,
    Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • S. Tauber
    Jordan Valley Innovation Center, Missouri State University, Springfield, Missouri
  • S. C. G. Tseng
    TissueTech, Inc.,Ocular Surface Center, Ocular Surface Res & Educ Fndtn, Miami, Florida
  • Footnotes
    Commercial Relationships  K.S. Bower, None; C.D. Coe, None; D.S. Ryan, None; L. Peppers, None; R.K. Sia, None; R.S. Howard, None; S. Tauber, None; S.C.G. Tseng, TissueTech, Inc., P; TissueTech, Inc., I; TissueTech, Inc., E; TissueTech, Inc., C.
  • Footnotes
    Support  NIH, NEI, EY014768
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2857. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Sutureless Cryopreserved Amniotic Membrane Graft (ProKeraTM) and Wound Healing After Photorefractive Keratectomy (PRK)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      K. S. Bower, C. D. Coe, D. S. Ryan, L. Peppers, R. K. Sia, R. S. Howard, S. Tauber, S. C. G. Tseng; Sutureless Cryopreserved Amniotic Membrane Graft (ProKeraTM) and Wound Healing After Photorefractive Keratectomy (PRK). Invest. Ophthalmol. Vis. Sci. 2010;51(13):2857.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To evaluate the early effects of a sutureless cryopreserved amniotic membrane graft (ProKeraTM, Bio-Tissue, Inc. Miami, FL) on corneal wound healing after PRK in terms of epithelial defect area (EDA) and mean time to re-epithelialization (RE).

Methods: : This was a prospective, open-label, non-randomized, control trial of 29 subjects undergoing PRK at the Walter Reed Center for Refractive Surgery. A 20% ethanol solution was used to create a standard 9.0 mm epithelial defect followed by photoablation with Wavelight ALLEGRETO WAVE Eye-Q 400 MHz laser platform (Wavelight AG, Erlangen, Germany). After surgery, a high oxygen transmissible bandage contact lens (BCL) was applied on the dominant eye and ProKera on the non-dominant eye. Postop regimen was otherwise identical for both eyes. Patients were divided into 3 groups based on duration of ProKera: Group 1: ProKera until complete RE (n=9), Group 2: ProK removed on postoperative day (POD) 3 (n=15) and Group 3: ProKera removed on POD 1 (n=5). A BCL was inserted if there was a defect upon ProKera removal. Patients were seen daily after surgery until RE was documented in both eyes. Major outcome measures were EDA and mean time to RE. Wilcoxon signed-rank test was used to compare ProKera to BCL and p<0.05 was considered significant.

Results: : The EDA in ProKera eyes was significantly smaller when compared to BCL eyes on POD 1 in Group 1 (43.06mm2 vs. 56.79 mm2; p=0.03) and Group 2 (47.45mm2 vs. 56.6 mm2; p=0.05) but not in Group 3 (48.00mm2 vs. 48.40mm2; p=1.0). The EDA measured in ProKera eyes and BCL eyes on POD 2-5 post-surgery were not significantly different in any group. Time to RE measured in days was not significantly different between the ProKera and BCL eyes in any Group 1: 4.6 vs. 4.1, p=0.41; Group 2: 4.8 vs. 3.9, p= 0.11; Group 3: 3.4 vs. 3.2, p= 0.32. ProKera was reasonably well-tolerated with few significant adverse effects.

Conclusions: : ProKera promoted corneal RE on day 1 post PRK but was not superior over BCL in hastening complete RE of the cornea. Its effect on corneal clarity and quality of vision are still under investigation. The role of ProKera in modulating wound healing after PRK remains speculative.

Clinical Trial: : www.clinicaltrials.gov NCT00915759

Keywords: cornea: epithelium • wound healing • refractive surgery: PRK 
© 2010, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept